109 related articles for article (PubMed ID: 82542)
21. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells.
Boumsell L; Bernard A; Lepage V; Degos L; Lemerle J; Dausset J
Eur J Immunol; 1978 Dec; 8(12):900-4. PubMed ID: 83236
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin and other surface antigens of cells of the immune system.
Takahashi T; Old LJ; McIntire KR; Boyse EA
J Exp Med; 1971 Oct; 134(4):815-32. PubMed ID: 4106485
[TBL] [Abstract][Full Text] [Related]
23. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
24. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
Lynch DH; Gurish MF; Daynes RA
Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
[TBL] [Abstract][Full Text] [Related]
25. Modulation of mouse anti-SRBC antibody responses by placental extracts. II. Antigen specificity and regulatory role of B and T cell populations affected by two distinct placental fractions.
Bobé P; Kanellopoulos-Langevin C; Bleux C; Voisin GA
J Immunol; 1986 Jan; 136(2):574-81. PubMed ID: 2416814
[TBL] [Abstract][Full Text] [Related]
26. Thymus-derived (T) cell immunoglobulins. Presence of a receptor site for IgG and absence of large amounts of "buried" Ig determinants on T cells.
Grey HM; Kubo RT; Cerottini JC
J Exp Med; 1972 Nov; 136(5):1323-8. PubMed ID: 4117193
[TBL] [Abstract][Full Text] [Related]
27. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
28. Impact of Ig-anti-Ig column fractionation on T-lymphocyte functions.
Rubin B; Jorgensen PN; Guttler F; Hoier-Madsen M
Scand J Immunol; 1976; 5(4):345-59. PubMed ID: 59945
[TBL] [Abstract][Full Text] [Related]
29. Rosette forming cells in the spleens of mice with lymphoid and myeloid leukemia.
Gabrilovac J; Boranić M
Exp Hematol; 1977 Jan; 5(1):13-8. PubMed ID: 319009
[TBL] [Abstract][Full Text] [Related]
30. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
31. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
Galli SJ; Adams RA
Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
[No Abstract] [Full Text] [Related]
32. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro.
Kawanishi H; Saltzman LE; Strober W
J Exp Med; 1983 Feb; 157(2):433-50. PubMed ID: 6185611
[TBL] [Abstract][Full Text] [Related]
33. Functional properties of T and B lymphocytes in cell-mediated immunity.
Petrányl GG
Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
[No Abstract] [Full Text] [Related]
34. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. I. Virus replication in lymphocytes infected with Friend virus and cultures in diffusion chambers in vivo.
Cerny J; Fistel SH; Hensgen PA
Int J Cancer; 1976 Aug; 18(2):176-88. PubMed ID: 182644
[TBL] [Abstract][Full Text] [Related]
35. Adaptation to tissue culture of the murine leukemia ASL1, a high producer of TL (thymus leukemia) antigen.
Williams JL; Stanton TH; Wolcott RM
Tissue Antigens; 1975 Nov; 6(5):335-41. PubMed ID: 1082668
[TBL] [Abstract][Full Text] [Related]
36. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies.
Ran M; Klein G; Witz IP
Int J Cancer; 1976 Jan; 17(1):90-7. PubMed ID: 55397
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-mediated in vitro sensitization of T-lymphocytes. I; Detection of murine leukemia virus-associated antigens.
Treves AJ; Feldman M; Kaplan HS
J Natl Cancer Inst; 1977 May; 58(5):1527-9. PubMed ID: 192905
[TBL] [Abstract][Full Text] [Related]
38. Blocking antigen-antibody complexes on the T-lymphocyte activation during in vitro incubation before adoptive transfer.
Kontiainen S; Mitchison NA
Immunology; 1975 Mar; 28(3):523-33. PubMed ID: 47836
[TBL] [Abstract][Full Text] [Related]
39. Specific induction of syngeneic cytotoxic T lymphocytes by solubilized tumor antigen: fractionation of the specific R-MuLV-induced leukemia antigen.
Alaba O; Law LW
J Immunol; 1980 Jul; 125(1):414-9. PubMed ID: 6155403
[TBL] [Abstract][Full Text] [Related]
40. Functional heterogeneity of murine lymphoid cells. V. Lymphocytes lacking detectable surface theta or immunoglobulin determinants.
Stobo JD; Rosenthal AS; Paul WE
J Exp Med; 1973 Jul; 138(1):71-88. PubMed ID: 4123830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
